Maxim Kots - Global Clinical Development, Chiesi Farmaceutici SpA

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 32 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate Versus Patients Initiating LABD Without ICS

David Price,William Henley,Jose Eduardo Delfini Cancado,Leonardo M. Fabbri,Huib A. M. Kerstjens,Alberto Papi,Nicolas Roche,Elif Sen,Dave Singh,Claus F. Vogelmeier,Elena Nudo,Victoria Carter,Derek Skinner,Rebecca Vella,Joan B. Soriano,Maxim Kots,George Georges

PRAGMATIC AND OBSERVATIONAL RESEARCH (2024): 1-16

引用0浏览0WOS引用

EE556 Beclometasone/Formoterol/Glycopyrronium Vs. Fixed and Open Combinations of Inhaled Corticosteroids, Long-Acting B2-Agonist, and Long-Acting Muscarinic Antagonist in Adults with Uncontrolled Asthma: A Network Meta-Analysis

M. Orlovic, G. Nikolaidis,D. Tzelis, I. Barouma,A. Vele,M. Kots, M. van der Deijl,A. Madoni

Value in healthno. 12 (2023): S159-S160

引用0浏览0引用

Pneumonia risk associated with commencing ICS of varying particle size

D. Price,W. Henley,V Carter,D. Skinner,R. Vella,A. Papi,L. Fabbri,H. Kerstjens,N. Roche, D. Singh,C. Vogelmeier,E. Sen,J. Cancado,M. Kots,E. Nudo,S. Barile,G. Georges

RESPIROLOGY (2023): 90-91

引用0浏览0引用

Associations of Imaging Biomarkers with Physiological Markers of Small Airways Dysfunction in Asthma in the ATLANTIS Study

Franz Aaron Clemeno,Alexander Bell,Matthew Richardson,Janwillem Kocks,Simonetta Baldi,Judith Vonk,Marika Leving,Bertine Flokstra-De Blok,Leonardo Fabbri,Monica Kraft,Alberto Papi,Klaus Rabe,Maarten Van Den Berge,Tessa Kole,Dave Singh,Craig Galban,Maxim Kots,Christopher Brightling,Salman Siddiqui

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

Cluster Analysis to Identify Distinct Clinical Asthma Phenotypes Within ATLANTIS

Pauline Kuks,Tatiana Karp,Jorine Hartman,Monica Kraft, Salman Siddiqui,Leonardo Fabbri,Klaus Rabe,Alberto Papi,Chris Brightling,Dave Singh,Maxim Kots,Thys Van Der Molen,Huib Kerstjens,Irene Heijink,Pouwels Dirk-Jan Slebos,Maarten Van Den Berge

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

The MiSTIC Study Design: Medium Strength Triple Therapy Vs High Strength ICS/LABA for Adult Patients With Asthma Uncontrolled on Medium Strength ICS/LABA

K. Kostikas,E. Topole, D. Singh,G. G. Brusselle,M. Kots,A. Vele,G. Georges,A. Papi

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

引用0浏览0引用

Comparison of Bronchodilator Reversibility to Spirometry and Oscillometry in the ATLANTIS Study

Franz Aaron Clemeno,Janwillem Kocks,Leonardo Fabbri,Monica Kraft,Alberto Papi,Klaus Rabe,Maarten Van Den Berge,Dave Singh,Maxim Kots,Christopher Brightling, Salman Siddiqui

EUROPEAN RESPIRATORY JOURNAL（2023）

引用0浏览0引用

Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients

D. Price,W. Henley,V Carter,D. Skinner,R. Vella,A. Papi,L. M. Fabbri,H. A. Kerstjens,N. Roche,D. Singh,C. F. Vogelmeier,E. Sen,J. E. D. Cancado,M. Kots,E. Nudo,S. Barile,G. Georges,W. Henley

05.01 - Airway pharmacology and treatment (2022)

引用0浏览0引用

Predicting Pneumonia Events in COPD Patients Using Medical Records

D. B. Price,W. Henley,V. Carter,D. Skinner, L. Alexander,R. Vella,A. Papi,L. M. Fabbri,H. A. Kerstjens,N. Roche,D. Singh, C. Volgemeier,E. Sen,J. Cancado,M. Kots,E. Nudo,S. Barile,G. Georges

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2022）

引用1浏览0引用

CHF 6366: A Novel Dual Potent Bronchodilator with Antimuscarinic and Beta-2 Agonist Activity - Results from the First-in-Human Healthy Male Volunteers Trial

M. Kots, D. Singh, P. Maison-Blanche, A. Piccinno,A. Guasconi

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2021）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn